Novasep

Mar 03, 2020

Novasep Implements New Biopharma Solutions Business Unit, Led by Cédric Volanti

Dec 03, 2019

Novasep Launches oXYgene(TM), a Fully Integrated Offer for Boosting Viral Vector Production

Oct 01, 2019

Senefill, Novasep's Commercial Facility for Aseptic Filling and Finishing Operations, Is Now Ready to Operate

Apr 18, 2019

NOVASEP and THERAVECTYS Enter Into a New License Agreement on DNA Flap Technology for GMP Manufacturing of Lentiviral Vectors

Feb 05, 2019

Enzene Biosciences Chooses Novasep BioSC® Pilot Chromatography for Its Automated End to End Continuous Manufacture of mAb

Oct 02, 2018

Novasep Opens EUR27m New Viral Vector Commercial Production Facility

Aug 27, 2018

Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s

Jun 11, 2018

Novasep Launches BioSC® Pilot, Breakthrough Chromatography and DSP Skid for Biologics Purification

May 03, 2018

Novasep Invests EUR10M in "SeneFill", Its New Facility for Commercial Aseptic Fill & Finish Operations

Apr 25, 2018

Novasep Announces 2017 Financial Results

Dec 12, 2017

Novasep Signs Manufacturing Agreement with Clinical-stage Biopharmaceutical Company Tetraphase for Eravacycline API

Dec 06, 2017

Novasep Invests EUR17 M in "mAbulous", its Dedicated cGMP Monoclonal Antibody (mAb) Production Facility

Oct 24, 2017

Novasep Invests 4 Million Euros to Expand its Cryogenic Production Capacity

May 31, 2017

Novasep Announces 2016 Financial Results